These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 34521762)

  • 1. High-Flow Nasal Cannula and COVID-19: A Clinical Review.
    Crimi C; Pierucci P; Renda T; Pisani L; Carlucci A
    Respir Care; 2022 Feb; 67(2):227-240. PubMed ID: 34521762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High flow nasal cannula for adult acute hypoxemic respiratory failure in the ED setting.
    Long B; Liang SY; Lentz S
    Am J Emerg Med; 2021 Nov; 49():352-359. PubMed ID: 34246166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of failure of high flow nasal cannula failure in acute hypoxemic respiratory failure due to COVID-19.
    Garner O; Dongarwar D; Salihu HM; Barrantes Perez JH; Abraham J; McBride C; Mathew S; Antony P; Collins K; Richards KL; Howard CM
    Respir Med; 2021; 185():106474. PubMed ID: 34044293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of High-Flow Nasal Cannula and Noninvasive Ventilation in Acute Hypoxemic Respiratory Failure Due to Severe COVID-19 Pneumonia.
    Nair PR; Haritha D; Behera S; Kayina CA; Maitra S; Anand RK; Ray BR; Soneja M; Subramaniam R; Baidya DK
    Respir Care; 2021 Dec; 66(12):1824-1830. PubMed ID: 34584010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission.
    Agarwal A; Basmaji J; Muttalib F; Granton D; Chaudhuri D; Chetan D; Hu M; Fernando SM; Honarmand K; Bakaa L; Brar S; Rochwerg B; Adhikari NK; Lamontagne F; Murthy S; Hui DSC; Gomersall C; Mubareka S; Diaz JV; Burns KEA; Couban R; Ibrahim Q; Guyatt GH; Vandvik PO
    Can J Anaesth; 2020 Sep; 67(9):1217-1248. PubMed ID: 32542464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study.
    Procopio G; Cancelliere A; Trecarichi EM; Mazzitelli M; Arrighi E; Perri G; Serapide F; Pelaia C; Lio E; Busceti MT; Pelle MC; Ricchio M; Scaglione V; Davoli C; Fusco P; La Gamba V; Torti C; Pelaia G
    Ther Adv Respir Dis; 2020; 14():1753466620963016. PubMed ID: 33070706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High flow nasal cannula in COVID-19: a literature review.
    Gürün Kaya A; Öz M; Erol S; Çiftçi F; Çiledağ A; Kaya A
    Tuberk Toraks; 2020 Jul; 68(2):168-174. PubMed ID: 32755117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Rationale for Use of High Flow Nasal Cannula for Select Patients With Suspected or Confirmed Severe Acute Respiratory Syndrome Coronavirus-2 Infection.
    Suffredini DA; Allison MG
    J Intensive Care Med; 2021 Jan; 36(1):9-17. PubMed ID: 32912049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive ventilation and high-flow nasal cannula in patients with acute hypoxemic respiratory failure by covid-19: A retrospective study of the feasibility, safety and outcomes.
    Costa WNDS; Miguel JP; Prado FDS; Lula LHSM; Amarante GAJ; Righetti RF; Yamaguti WP
    Respir Physiol Neurobiol; 2022 Apr; 298():103842. PubMed ID: 35026479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-flow nasal cannula oxygen therapy in hypoxic patients with COVID-19 pneumonia: A retrospective cohort study confirming the utility of respiratory rate index.
    Takeshita Y; Terada J; Hirasawa Y; Kinoshita T; Tajima H; Koshikawa K; Kinouchi T; Isaka Y; Shionoya Y; Tada Y; Tsushima K
    Respir Investig; 2022 Jan; 60(1):146-153. PubMed ID: 34772644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Noninvasive Respiratory Support Therapies to Treat COVID-19.
    Colaianni-Alfonso N; Montiel G; Castro-Sayat M; Siroti C; Laura Vega M; Toledo A; Haedo S; Previgliano I; Mazzinari G; Miguel Alonso-Íñigo J
    Respir Care; 2021 Dec; 66(12):1831-1839. PubMed ID: 34290078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of noninvasive positive pressure ventilation and high-flow nasal cannula oxygen therapy on the clinical efficacy of coronavirus disease 2019 patients with acute respiratory distress syndrome].
    Zhao Z; Cao H; Cheng Q; Li N; Zhang S; Ge Q; Shen N; Yang L; Shi W; Bai J; Meng Q; Wu C; Wang B; Li Q; Yao G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jun; 33(6):708-713. PubMed ID: 34296691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-flow nasal cannula oxygen therapy for the treatment of acute respiratory failure secondary to SARS-CoV-2 pneumonia out of ICU.
    Castro S; Pedrero S; Ruiz LA; Serrano L; Zalacain R; Pérez-Fernández S; Iriberri M; Cabriada V
    Clin Respir J; 2023 Sep; 17(9):905-914. PubMed ID: 37537998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physicians.
    Koyauchi T; Suzuki Y; Inoue Y; Hozumi H; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Inui N; Suda T
    Respir Investig; 2022 Nov; 60(6):779-786. PubMed ID: 36153288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of surgical mask with high-flow nasal cannula (HFNC) leads to improved oxygenation in patients with COVID-19: a set of case reports].
    Smaha J; Kužma M; Brázdilová K; Jackuliak P; Payer J
    Vnitr Lek; 2021; 67(E-2):29-33. PubMed ID: 34074102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Aerosol Formation During High-Flow Nasal Cannula Treatment in Critically Ill Subjects.
    Bem RA; van Mourik N; Klein-Blommert R; Spijkerman IJ; Kooij S; Bonn D; Vlaar AP
    Respir Care; 2021 Jun; 66(6):891-896. PubMed ID: 33536316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success.
    Chandel A; Patolia S; Brown AW; Collins AC; Sahjwani D; Khangoora V; Cameron PC; Desai M; Kasarabada A; Kilcullen JK; Nathan SD; King CS
    Respir Care; 2021 Jun; 66(6):909-919. PubMed ID: 33328179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen debt as a predictor of high-flow nasal cannula therapy failure in SARS-CoV-2 patients with acute respiratory failure: A retrospective cohort study.
    Michel PG; Claudia PH; Andrea RS; Maria DA; Henry RA
    Heart Lung; 2024; 64():176-181. PubMed ID: 38278127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 pandemic and non invasive respiratory management: Every Goliath needs a David. An evidence based evaluation of problems.
    Winck JC; Ambrosino N
    Pulmonology; 2020; 26(4):213-220. PubMed ID: 32362507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High flow nasal cannula oxygen therapy in adults with COVID-19 respiratory failure. A case report.
    Karamouzos V; Fligou F; Gogos C; Velissaris D
    Monaldi Arch Chest Dis; 2020 Jun; 90(2):. PubMed ID: 32512988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.